CANY
VIR icon

Caxton Associates (New York)’s Vir Biotechnology VIR Stock Holding History

Caxton Associates (New York)’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		$524K Hold
71,348
– – 0.02% 319
2024
Q3 		$534K Buy
71,348
+11,723
+20% +$87.8K 0.02% 351
2024
Q2 		$531K Buy
+59,625
New +$531K 0.02% 329